Protecting Your Family from Thyroid Cancer
Thyroid cancer is the main form of cancer of the
glandular (endocrine) system. In the US, there are
19,500 cases per year, mostly in women. One of the
main causes of thyroid cancer is exposure to radioactivity.
For example, people who were exposed to radiation
therapy as children have many more thyroid tumors
than those who were not. In the aftermath of the Chernobyl
nuclear disaster in 1986 there was a 1000-fold increase
in thyroid cancer in that part of the world. Those
at the greatest risk are children, and the younger
they are, the more vulnerable.
How does radioactivity cause thyroid cancer? The
thyroid gland craves iodine. When a radioactive form
of iodine is released into the atmosphere, as part
of nuclear fallout, it eventually gets into people.
This is quickly taken up by the thyorid gland, where
it incites the formation of benign or malignant tumors.
Happily, there is a substance that can block the
uptake of radioactive iodine by the thyroid. It is
called potassium iodide (abbreviated KI).
Potassium iodide is an old 19th century panacea that
was included in the notorious Hoxsey "cancer
cure." It is making a comeback in conventional
medicine. .
Both the US Food and Drug Administration (FDA)
and the World Health Organization (WHO) have
now recommended the use of potassium iodide for preventing
thyroid cancer in case of a release of radioactivity
into the atmosphere. The FDA has declared potassium
iodide "a safe and effective means by which
to prevent radio[active] iodine uptake by the thyroid
glandand thus to obviate the risk of thyroid cancer
in the event of a radiation emergency." When
these regulations were issued, authorities were thinking
of a Chernobyl-type accident. In the post-September
11 world, we have even greater fears on our mind.
While the risk of nuclear terrorism is still small,
one should consider steps to protect yourself and
your family. Authorities agree that potassium iodide
should be taken prior to, or shortly after, radiation
exposure. By doing so, you can block dangerous radioactive
iodine by nearly 100 percent. But, frankly, who knows
what conditions would be like in the wake of such
a disaster. Wouldn't it be better to be prepared against
this admittedly remote, yet potentially devastating,
risk?
Potassium iodide is sold as an over-the-counter (OTC)
drug under various names, such as Rad Block¨.
It comes in bottles of 200 tablets. Each tablet contains
65 mg of potassium iodide which yields 50 miligrams
of useable iodine. The FDA recommends two tablets
(130 milligrams) per day for adults and adolescents
and 65 milligrams per day for children. Potassium
iodine is generally safe, but not without some potentially
serious adverse effects. People with allergies to
iodine should not take it and those with impaired
kidney function may experience some other serious
side effects. They should only take it under a doctor's
supervision. Don't take it as a preventative unless
there is a confirmed risk of radioactivity.
There is no way to get this much iodine from salt
or from supplements. You would need to eat about seven
pounds of iodized salt (a dangerous idea!) to get
this much iodine. Sea Kelp Tablets contain just 0.15
milligram of iodine per tablet, so you would need
500 of them to equal one tablet of potassium iodide.
There are currently websites selling potassium iodide.
You can find them by entering the words "potassium
iodide" into a search engine, such as Google.
Avoid fly-by-night operation that seem to have sprung
up after September 11th. There are many rip-offs out
there. You may be able to get it from a cooperative
pharmacist. The cost should be modest, between $15
and $20 for a 200-tablet bottle. One bottle should
be enough for each person in the family.
Let's hope the bottles just sit on the shelf and
never get used! But on the outside chance that we
might need it, wouldn't it be reassuring to have this
for ourselves and our families?
Here at the Moss Reports
I have been preparing my eight lectures for the professional-level
course on Integrative Cancer Therapy at Thomas
Jefferson University in Philadelphia that takes place
on the coming weekend (November 16th and 17th).
Registration is practically completed but there may
be a few more spaces left. For information contact
Sharifa Pettigrew at the Center for Integrative
Medicine at Thomas Jefferson University Hospital,
215-503-0720 or email: sharifa.pettigrew@mail.tju.edu.
This week I made some important additions to the
www.cancerdecisions.com
website. In the Health
Professionals section (which is open to all)
you will find some more of my lectures from over the
years. I have added my speech on "The Morality
of Oncology," which I gave to the German
Society for Biological Cancer Therapy (the GfBK) at
their 10th annual meeting in Celle, Germany, May,
2000.
Please visit us at
www.cancerdecisions.com for lots of useful information
and free back issues of this weekly newsletter. You
can also order a Moss report there or from our coordinator
Diane Galbo. Our business address is now PO
Box 8183, State College, PA 16803. Our
new phone number is 814-238-3369.
Our toll-free number remains 800-980-1234.
Till next week...Best wishes for your safety, good
health and peace of mind!
Ralph W. Moss, Ph.D.

IMPORTANT DISCLAIMER
The news and other items in this newsletter are
intended for informational purposes only. Nothing
in this newsletter is intended to be a substitute
for professional medical advice.
|